KRYS insider transaction filings

Krystal Biotech, Inc. — 31 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-14. Screen KRYS transaction legs live →

FiledFormInsiderReported transactionsSource
2026-08-144ROSSI DINO A — DirectorGift (G): 3,691 @ $0 · Sale (S): 341 @ $325.60 · Sale (S): 2,287 @ $326.60 · Sale (S): 5,226 @ $327.39 · Sale (S): 1,687 @ $328.52 · Sale (S): 7,428 @ $329.60 · +3 moreEDGAR
2026-06-264Thomas John Charles — EVP, General CounselOption exercise (M): 1,000 @ $179.25 · Sale (S): 1,000 @ $347.27 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2026-06-054Krishnan Suma — President, R&D, Director, 10% ownerSale (S): 320 @ $300.75 · Sale (S): 593 @ $302.25 · Sale (S): 247 @ $303.17 · Sale (S): 400 @ $304.89 · Sale (S): 480 @ $305.87 · Sale (S): 1,348 @ $307.09 · +5 moreEDGAR
2026-06-054Krishnan Krish S — President and CEO, Director, 10% ownerSale (S): 320 @ $300.75 · Sale (S): 640 @ $302.24 · Sale (S): 176 @ $303.17 · Sale (S): 544 @ $304.81 · Sale (S): 589 @ $306.33 · Sale (S): 11,461 @ $307.68 · +5 moreEDGAR
2026-05-274Thomas John Charles — EVP, General CounselSale (S): 642 @ $302.03EDGAR
2026-03-064Krishnan Suma — President, R&D, Director, 10% ownerSale (S): 407 @ $257.32 · Sale (S): 589 @ $258.54 · Sale (S): 668 @ $259.61 · Sale (S): 3,667 @ $260.37 · Sale (S): 2,931 @ $261.41 · Sale (S): 1,938 @ $262.35 · +4 moreEDGAR
2026-03-064Krishnan Krish S — President and CEO, Director, 10% ownerSale (S): 483 @ $257.31 · Sale (S): 470 @ $258.38 · Sale (S): 1,377 @ $259.87 · Sale (S): 3,128 @ $260.49 · Sale (S): 2,962 @ $261.41 · Sale (S): 2,380 @ $262.44 · +4 moreEDGAR
2026-03-034ROMANO KATHRYN — Chief Accounting OfficerOption exercise (M): 7,500 @ $0 · Tax withholding (F): 3,262 @ $275.64 · Option exercise (M): 550 @ $0 · Tax withholding (F): 240 @ $275.64 · Sale (S): 750 @ $267.60 · Option exercise (M): 7,500 (derivative) @ $0 · +3 moreEDGAR
2026-03-034Krishnan Suma — President, R&D, Director, 10% ownerOption exercise (M): 22,500 @ $0 · Tax withholding (F): 10,236 @ $275.64 · Option exercise (M): 4,000 @ $0 · Tax withholding (F): 1,820 @ $275.64 · Option exercise (M): 8,750 @ $0 · Tax withholding (F): 3,981 @ $275.64 · +9 moreEDGAR
2026-03-034Krishnan Krish S — President and CEO, Director, 10% ownerOption exercise (M): 8,750 @ $0 · Tax withholding (F): 3,981 @ $275.64 · Option exercise (M): 26,250 @ $0 · Tax withholding (F): 11,942 @ $275.64 · Option exercise (M): 5,725 @ $0 · Tax withholding (F): 2,605 @ $275.64 · +9 moreEDGAR
2026-03-034JANNEY DANIEL — DirectorSale (S): 9,430 @ $275.45 · Sale (S): 2,373 @ $276.17EDGAR
2026-02-264JANNEY DANIEL — DirectorOption exercise (M): 37,895 @ $2.46 · Sale (S): 569 @ $262.91 · Sale (S): 1,733 @ $264.12 · Sale (S): 3,557 @ $265.08 · Sale (S): 8,986 @ $266.18 · Sale (S): 11,673 @ $266.97 · +16 moreEDGAR
2026-02-234ROSSI DINO A — DirectorOption exercise (M): 18,950 @ $8.79 · Sale (S): 8,116 @ $260.49 · Sale (S): 10,834 @ $262.10 · Option exercise (M): 18,950 (derivative) @ $0EDGAR
2026-02-114ROMANO KATHRYN — Chief Accounting OfficerOption exercise (M): 12,500 @ $63.55 · Sale (S): 2,000 @ $270.56 · Sale (S): 5,700 @ $271.66 · Sale (S): 2,824 @ $272.51 · Sale (S): 928 @ $273.71 · Sale (S): 552 @ $274.64 · +4 moreEDGAR
2025-12-054Krishnan Suma — President, R&D, Director, 10% ownerSale (S): 700 @ $214.25 · Sale (S): 600 @ $215.49 · Sale (S): 1,400 @ $216.97 · Sale (S): 3,593 @ $218.83 · Sale (S): 5,419 @ $219.68 · Sale (S): 2,627 @ $220.52 · +11 moreEDGAR
2025-12-054Krishnan Krish S — President and CEO, Director, 10% ownerSale (S): 956 @ $214.28 · Sale (S): 344 @ $215.48 · Sale (S): 1,600 @ $217.04 · Sale (S): 2,577 @ $218.72 · Sale (S): 5,693 @ $219.55 · Sale (S): 2,625 @ $220.34 · +11 moreEDGAR
2025-07-164Krishnan Suma — President, R&D, Director, 10% ownerSale (S): 13,335 @ $150.29 · Sale (S): 100 @ $151 · Sale (S): 2,236 @ $150.68 · Sale (S): 800 @ $151.79 · Sale (S): 1,529 @ $150 · Sale (S): 13,400 @ $150.30 · +3 moreEDGAR
2025-07-164Krishnan Krish S — President and CEO, Director, 10% ownerSale (S): 13,400 @ $150.30 · Sale (S): 2,184 @ $150.68 · Sale (S): 900 @ $151.79 · Sale (S): 1,389 @ $150 · Sale (S): 13,335 @ $150.29 · Sale (S): 100 @ $151 · +3 moreEDGAR
2025-07-114Krishnan Suma — President, R&D, Director, 10% ownerSale (S): 200 @ $150.14 · Sale (S): 6,500 @ $150.23 · Sale (S): 300 @ $151.39 · Sale (S): 200 @ $150.07 · Sale (S): 6,627 @ $150.22 · Sale (S): 300 @ $151.39EDGAR
2025-07-114Krishnan Krish S — President and CEO, Director, 10% ownerSale (S): 200 @ $150.07 · Sale (S): 6,627 @ $150.22 · Sale (S): 300 @ $151.39 · Sale (S): 200 @ $150.14 · Sale (S): 6,500 @ $150.23 · Sale (S): 300 @ $151.39EDGAR
2025-06-304Mazzacco Catherine — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2025-06-304Sutherland Everett Rand — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2025-06-304Mason Christopher — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2025-06-304Gangolli Julian S — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2025-06-304ROSSI DINO A — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2025-06-304JANNEY DANIEL — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2025-03-134Krishnan Suma — President, R&D, Director, 10% ownerSale (S): 1,639 @ $175.97 · Sale (S): 4,579 @ $176.88 · Sale (S): 10,937 @ $177.66 · Sale (S): 6,514 @ $178.76 · Sale (S): 1,331 @ $179.55 · Sale (S): 1,100 @ $175.83 · +4 moreEDGAR
2025-03-134Krishnan Krish S — President and CEO, Director, 10% ownerSale (S): 1,100 @ $175.83 · Sale (S): 4,944 @ $176.80 · Sale (S): 10,931 @ $177.62 · Sale (S): 6,769 @ $178.77 · Sale (S): 1,256 @ $179.57 · Sale (S): 1,639 @ $175.97 · +4 moreEDGAR
2025-02-284ROMANO KATHRYN — Chief Accounting OfficerTax withholding (F): 2,268 @ $176.39 · Sale (S): 750 @ $175.22 · Option exercise (M): 5,000 @ $0 · Tax withholding (F): 2,315 @ $179.25 · Option exercise (M): 7,500 @ $0 · Tax withholding (F): 3,471 @ $179.25 · +4 moreEDGAR
2025-02-284Krishnan Krish S — President and CEO, Director, 10% ownerTax withholding (F): 4,721 @ $176.39 · Option exercise (M): 12,500 @ $0 · Tax withholding (F): 5,786 @ $179.25 · Option exercise (M): 8,750 @ $0 · Tax withholding (F): 4,050 @ $179.25 · Option exercise (M): 26,250 @ $0 · +11 moreEDGAR
2025-02-284Krishnan Suma — President, R&D, Director, 10% ownerTax withholding (F): 3,286 @ $176.39 · Option exercise (M): 7,500 @ $0 · Tax withholding (F): 3,471 @ $179.25 · Option exercise (M): 22,500 @ $0 · Tax withholding (F): 10,414 @ $179.25 · Option exercise (M): 12,500 @ $0 · +10 moreEDGAR

Recent 8-K events — Krystal Biotech, Inc.

FiledFormItems reportedSource
2026-08-038-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-218-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-208-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-048-K9.01 — Financial Statements and ExhibitsEDGAR
2026-02-178-K2.02 — Results of Operations and Financial ConditionEDGAR
2026-01-128-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-088-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-238-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-038-K2.02 — Results of Operations and Financial ConditionEDGAR
2025-10-228-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=KRYS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →